Surgery for Pediatric Cholesteatoma Clinical Presentation

  • Author: Peter S Roland, MD; Chief Editor: Glenn C Isaacson, MD, FACS, FAAP   more...
 
Updated: Mar 25, 2010
 

History

  • The hallmark symptom of cholesteatoma is unremitting (or frequently recurrent) painless discharge from the ear (ie, otorrhea).
  • Hearing loss is also a common symptom of cholesteatoma. Large cholesteatomas fill the middle ear space with desquamated epithelium and interfere with sound transmission. Associated ossicular damage also can produce or magnify a conductive loss.
  • Dizziness is a relatively uncommon symptom of cholesteatoma but occurs if bony erosion produces a labyrinthine fistula or if the cholesteatoma lies directly on the footplate of stapes. Dizziness is a worrisome symptom because it may presage the development of more serious complications.
  • Occasionally, cholesteatoma presents initially with the symptoms of CNS complications, sigmoid sinus thrombosis,[3] epidural abscess, or meningitis.
Next

Physical

  • Upon physical examination, the most common signs of cholesteatoma are drainage and granulation tissue that are unresponsive to antimicrobial therapy.
  • Tympanic membrane (TM) perforation commonly accompanies cholesteatoma and is present in more than 90% of patients.
    • Congenital cholesteatomas are the exception.
    • Occasionally, a cholesteatoma produced by surgical implantation of squamous epithelium presents prior to disruption of the TM.
  • Quite frequently, the only finding upon physical examination is a canal filled with mucopus and granulation tissue.
    • Occasionally, the infection can be temporarily avoided with administration of ototopical antibiotic drops.
    • When ototopical therapy is successful, the surgeon often can observe a deep tympanic retraction pocket in the pars flaccida (the portion of the TM superior to the short process of the malleus) or in the posterior quadrant of the TM.
  • Very rarely, a cholesteatoma is initially identified on the basis of one of its complications.
    • An infection associated with the cholesteatoma can erupt through the inferior mastoid cortex and present as an abscess in the neck.
    • Occasionally, cholesteatoma initially manifests with the signs of central nervous complications, sigmoid sinus thrombosis, epidural abscess, or meningitis.
Previous
Next

Causes

The etiology of cholesteatoma varies, and at least 3 types are identified with different pathophysiologies.

  • Congenital cholesteatomas are caused by embryonic squamous epithelial rests.[4]
    • Congenital cholesteatomas are usually found in the anterior mesotympanum or in the peri eustachian tube area.
    • They are most commonly identified in early childhood (ie, age 6 mo to 5 y).
    • As congenital cholesteatomas expand, they can obstruct the eustachian tube, thus producing chronic middle ear fluid and conductive hearing loss.
    • They can also produce conductive hearing loss by expanding posteriorly to encase the ossicular chain.[5]
    • Unlike other forms of cholesteatoma, congenital cholesteatomas are often identified behind an intact and normal-appearing TM.
  • Primary acquired cholesteatomas are caused by TM retraction.
    • The classic primary acquired cholesteatoma is a result of increasingly severe medial retraction of the pars flaccida into the epitympanum.
      • As this process continues, the lateral wall of the epitympanum (ie, scutum) is slowly eroded, producing an enlarging defect in the lateral wall of the epitympanum.
      • The medially retracting TM continues to pass over the heads of the ossicles and into the posterior epitympanum. Ossicular destruction is common.
      • If the cholesteatoma passes posteriorly through the aditus ad antrum into the mastoid, erosion of the tegmen mastoideum with exposure of the dura and/or erosion of the lateral semicircular canal with deafness and vertigo can result.
    • A second type of primary acquired cholesteatoma arises when the posterior quadrant of the TM is retracted into the posterior middle ear.
      • The drum initially adheres to the long process of the incus.
      • As retraction continues medially and posteriorly, squamous epithelium envelops the superstructure of the stapes and retracts into the sinus tympani.
    • Primary acquired cholesteatomas arising from the posterior TM are likely to produce facial nerve injury and destruction of the stapedial superstructure.
  • Secondary acquired cholesteatoma is a consequence of injury to the TM.
    • Injury to the TM can be a perforation that occurs as a result of acute otitis media or trauma, or it can be caused by surgical manipulation of the drum.
    • Posterior marginal perforations are most likely to result in cholesteatoma formation.
    • Although considered unlikely to produce cholesteatomas, central perforations occasionally can result in cholesteatoma formation.
    • A procedure as simple as the insertion of tympanostomy tubes can implant squamous epithelium into the middle ear; this ultimately grows to produce a cholesteatoma.
    • Any deep retraction pocket can result in cholesteatoma formation, if the retraction pocket becomes deep enough to trap desquamated epithelium.
Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Peter S Roland, MD  Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development

Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Alcon Labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear Corp Honoraria Board membership; Med El Corp travel grants Consulting

Specialty Editor Board

Orval Brown, MD  Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas

Orval Brown, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

John E McClay, MD  Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School

John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association

Disclosure: Nothing to disclose.

Paul D Petry, DO, FACOP, FAAP  Consulting Staff, Freeman Pediatric Care, Freeman Health System

Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association

Disclosure: Nothing to disclose.

Chief Editor

Glenn C Isaacson, MD, FACS, FAAP  Professor of Otolaryngology-Head and Neck Surgery and Pediatrics, Temple University School of Medicine

Glenn C Isaacson, MD, FACS, FAAP is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Society of Pediatric Otolaryngology, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Covidien Honoraria Consulting

References
  1. Roland PS, Meyerhoff WL. Open-cavity tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):525-46. [Medline].

  2. Graham MD, Delap TG, Goldsmith MM. Closed tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):547-54. [Medline].

  3. Manolidis S, Kutz JW Jr. Diagnosis and management of lateral sinus thrombosis. Otol Neurotol. Sep 2005;26(5):1045-51. [Medline].

  4. Kazahaya K, Potsic WP. Congenital cholesteatoma. Curr Opin Otolaryngol Head Neck Surg. Oct 2004;12(5):398-403. [Medline].

  5. Potsic WP, Korman SB, Samadi DS, Wetmore RF. Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia. Otolaryngol Head Neck Surg. Apr 2002;126(4):409-14. [Medline].

  6. Dawes PJ, Leaper M. Paediatric small cavity mastoid surgery: second look tympanotomy. Int J Pediatr Otorhinolaryngol. Feb 2004;68(2):143-8. [Medline].

  7. De la Cruz A, Fayad JN. Detection and management of childhood cholesteatoma. Pediatr Ann. Jun 1999;28(6):370-3. [Medline].

  8. Dornhoffer JL, Colvin GB, North P. Evidence of residual disease in ossicles of patients undergoing cholesteatoma removal. Acta Otolaryngol. Jan 1999;119(1):89-92. [Medline].

  9. Busaba NY. Clinical presentation and management of labyrinthine fistula caused by chronic otitis media. Ann Otol Rhinol Laryngol. May 1999;108(5):435-9. [Medline].

  10. Anderson J, Caye-Thomasen P, Tos M. A comparison of cartilage palisades and fascia in tympanoplasty after surgery for sinus or tensa retraction cholesteatoma in children. Otol Neurotol. Nov 2004;25(6):856-63. [Medline].

  11. Bennett M, Warren F, Jackson GC, Kaylie D. Congenital cholesteatoma: theories, facts, and 53 patients. Otolaryngol Clin North Am. Dec 2006;39(6):1081-94. [Medline].

  12. Chadha NK, Jardine A, Owens D, et al. A multivariate analysis of the factors predicting hearing outcome after surgery for cholesteatoma in children. J Laryngol Otol. Nov 2006;120(11):908-13. [Medline].

  13. Golz A, Goldenberg D, Netzer A, et al. Cholesteatomas associated with ventilation tube insertion. Arch Otolaryngol Head Neck Surg. Jul 1999;125(7):754-7. [Medline].

  14. Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999;119(5):568-72. [Medline].

  15. Migirov L, Duvdevani S, Kronenberg J. Otogenic intracranial complications: a review of 28 cases. Acta Otolaryngol. Aug 2005;125(8):819-22. [Medline].

  16. Ottaviani F, Neglia CB, Berti E. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?. Acta Otolaryngol. 1999;119(4):462-7. [Medline].

  17. Semaan MT, Megerian CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am. Dec 2006;39(6):1143-59. [Medline].

  18. Thompson JW. Cholesteatomas. Pediatr Rev. Apr 1999;20(4):134-6. [Medline].

  19. Tierney PA, Pracy P, Blaney SP, Bowdler DA. An assessment of the value of the preoperative computed tomography scans prior to otoendoscopic 'second look' in intact canal wall mastoid surgery. Clin Otolaryngol Allied Sci. Aug 1999;24(4):274-6. [Medline].

Previous
Next
 
A typical audiogram demonstrating bilateral conductive hearing loss, which may be observed in an individual with a cholesteatoma.
The photo exhibits a large meatoplasty performed as part of an open cavity (canal wall down) mastoidectomy. A similar meatoplasty usually is necessary if a clean, dry, problem-free cavity is to be maintained.
An unenhanced CT scan demonstrating that the posterior canal wall has been eroded and the external auditory canal has filled with cholesteatoma, pus, and debris. Surprisingly, the middle ear appears relatively free of disease, a characteristic of primary acquired cholesteatomas.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.